CA1323629C - Process for the preparation of 5-arylidene and alkylidene-substituted hydantoins - Google Patents

Process for the preparation of 5-arylidene and alkylidene-substituted hydantoins

Info

Publication number
CA1323629C
CA1323629C CA000548024A CA548024A CA1323629C CA 1323629 C CA1323629 C CA 1323629C CA 000548024 A CA000548024 A CA 000548024A CA 548024 A CA548024 A CA 548024A CA 1323629 C CA1323629 C CA 1323629C
Authority
CA
Canada
Prior art keywords
phosphonate
hydantoin
alkyl
methyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000548024A
Other languages
English (en)
French (fr)
Inventor
John J. Wright
Nicholas A. Meanwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of CA1323629C publication Critical patent/CA1323629C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA000548024A 1986-09-29 1987-09-28 Process for the preparation of 5-arylidene and alkylidene-substituted hydantoins Expired - Fee Related CA1323629C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91304186A 1986-09-29 1986-09-29
US913,041 1986-09-29

Publications (1)

Publication Number Publication Date
CA1323629C true CA1323629C (en) 1993-10-26

Family

ID=25432878

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000548024A Expired - Fee Related CA1323629C (en) 1986-09-29 1987-09-28 Process for the preparation of 5-arylidene and alkylidene-substituted hydantoins

Country Status (10)

Country Link
KR (1) KR880003919A (es)
AT (1) AT398566B (es)
CA (1) CA1323629C (es)
CH (1) CH676846A5 (es)
ES (1) ES2007116A6 (es)
FI (1) FI874212L (es)
GR (1) GR871506B (es)
HU (2) HU208426B (es)
IT (1) IT1222755B (es)
PT (1) PT85805B (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011103289A3 (en) * 2010-02-17 2012-01-19 Jasco Pharmaceuticals, LLC Imidazole-2, 4-dione inhibitors of casein kinase 1
RU2781135C1 (ru) * 2022-02-18 2022-10-06 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Бензиламмонийная соль 4-этоксикарбонил-5-оксо-2-(2-оксо-2-фенилэтилиден)-2,5-дигидро-1h-пиррол-3-олата, проявляющая противомикробную активность

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0581250T3 (da) * 1992-07-31 1999-09-27 Hoechst Ag Fremgangsmåde til bioteknisk fremstilling af L-thienylalaniner i enantiomerren form ud fra 2-hydroxy-3-thienyl-acrylsyrer o
ATE553160T1 (de) 2002-02-21 2012-04-15 Basf Se Pigmente auf basis von lactam und deren verwendung in der herstellung gefärbter kunststoffe oder polymerer farbpartikel
EA200700117A1 (ru) 2004-06-24 2007-06-29 Инсайт Корпорейшн N-замещенные пиперидины и их применение в качестве фармацевтических препаратов

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011103289A3 (en) * 2010-02-17 2012-01-19 Jasco Pharmaceuticals, LLC Imidazole-2, 4-dione inhibitors of casein kinase 1
US9073903B2 (en) 2010-02-17 2015-07-07 Jasco Pharmaceuticals, LLC Imidazole-2,4-dione inhibitors of casein kinase 1
RU2781135C1 (ru) * 2022-02-18 2022-10-06 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Бензиламмонийная соль 4-этоксикарбонил-5-оксо-2-(2-оксо-2-фенилэтилиден)-2,5-дигидро-1h-пиррол-3-олата, проявляющая противомикробную активность

Also Published As

Publication number Publication date
FI874212A0 (fi) 1987-09-25
PT85805B (pt) 1990-08-31
HU208426B (en) 1993-10-28
GR871506B (en) 1988-01-20
CH676846A5 (en) 1991-03-15
PT85805A (en) 1987-10-01
IT8722055A0 (it) 1987-09-28
KR880003919A (ko) 1988-05-31
HUT49858A (en) 1989-11-28
IT1222755B (it) 1990-09-12
AT398566B (de) 1994-12-27
FI874212A7 (fi) 1988-03-30
HU9201172D0 (en) 1992-07-28
ATA247687A (de) 1994-05-15
FI874212L (fi) 1988-03-30
ES2007116A6 (es) 1989-06-01

Similar Documents

Publication Publication Date Title
CA1120481A (en) Aryl hydantoins
US4470989A (en) Neuroleptic n-oxacyclyl-alkylpiperidine derivatives
CH643545A5 (de) Verfahren zur herstellung chiral substituierter 2-imidazolin-5-one und deren verwendung.
CH633266A5 (en) Process for preparing 1,4-dihydropyridine compounds
US4535073A (en) Antihypertensive phosphono derivatives of hantzsch dihydropyridines
CH642353A5 (de) 2-methyl-dihydropyridin-verbindung, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel.
EP0004358B1 (de) N-Oxacyclyl-alkyl-piperidine, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen
EP0282502B1 (de) Imidazol-derivate
US4699914A (en) Imidazole group containing 2(1H)-pyridones and method for treating heart insufficiencies in humans
US4463001A (en) 6-Substituted 6H-dibenzo[b,d]pyran derivatives and process for their preparation
NO860471L (no) Fremgangsmaate for fremstilling av nye heterocykliske derivater.
EP0093945B1 (en) 1,4-dihydropyridine derivatives
AT398566B (de) Verfahren zur herstellung von 5-aryliden- und -alkylidensubstituierten hydantoinen
US4358450A (en) O-Alkylated oximes and pharmaceutical composition thereof
SU1572415A3 (ru) Способ получени производных имидазола или их фармацевтически приемлемых солей присоединени кислот
US4831046A (en) Tetrazole derivatives of 1,3-dioxane and thromboxane A2 antigonizing use thereof
EP0134096B1 (en) Aminopyrimidinone derivatives as histamine h2-antagonists
RU2049776C1 (ru) Производное хинона или его фармакологически приемлемые соли
EP0090275B1 (en) Isoxazole (5,4-b) pyridines
US4039670A (en) Butyrophenone compounds as psychotropics
NO860462L (no) Fremgangsmaate for fremstilling av et dihydropyridin.
NL8002853A (nl) Pyrazool(1,5-c)chinazolinen, werkwijze voor de bereiding van dergelijke verbindingen en geneesmiddel met als werkzaam bestanddeel een dergelijke verbinding.
US6132286A (en) Preparation of 1,2,5,6-tetra-hydro-3-carboalkoxypridines such as arecoline and salts of 1,2,5,6-tetrahydro-3-carboalkoxypridines and arecoline hydrobromide
RU2207340C2 (ru) Способ получения 1,2,3,9-тетрагидро-9-метил-3-[(2-метил-1н-имидазол-1-ил)метил]-4н-карбазол -4-она или его фармацевтически приемлемых солей
SU422157A3 (ru) Способ получения производных 4(зн)-хиназолинона

Legal Events

Date Code Title Description
MKLA Lapsed